Prot #APL-B-021-13: A Phase II Study of Plitidepsin in Patients with Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma

Project: Research project

StatusActive
Effective start/end date2/28/172/28/20

Funding

  • Pharma Mar, S.A. Sociedad Unipersonal (Prot #APL-B-021-13)